戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 608作成日:2026年10月23日

3-Bromopyridine → Tert-butyl 4-(pyridin-3-YL)piperazine-1-carboxylate

https://huagongshe.com/ja/reaction/608

反応式

関与物質

役割名称HCID仕込み量
反応物3-BromopyridineHCID 12286—
反応物tert-Butyl piperazine-1-carboxylateHCID 143452—
試薬Sodium t-butoxideHCID 23676156—
触媒Palladium (II) acetateHCID 4144353—
触媒2-Dicyclohexylphosphino-2',6'-diisopropoxybiphenylHCID 16217985—
溶媒1,4-DioxaneHCID 31275—
生成物Tert-butyl 4-(pyridin-3-YL)piperazine-1-carboxylateHCID 1167337337.96%

反応条件

温度100 °C

反応手順

diacetoxypalladium (0.072 g, 0.32 mmol) and RuPhos (0.301 g, 0.64 mmol) were stirred in 1,4-dioxane (11.36 ml) for 10 mins at 50 °C.tert-butyl piperazine-1-carboxylate (0.6 g, 3.22 mmol), 3-bromopyridine (0.310 ml, 3.22 mmol) and sodium tert-butoxide (0.464 g, 4.83 mmol) were added and the reaction mixture was stirred at 100 °C for 64 h. The reaction mixture was filtered through celite. The crude product was purified by flash silica chromatography, elution gradient 20 to 100% EtOAc in heptane. Pure fractions were evaporated to dryness to afford tert-butyl 4-(pyridin-3-yl)piperazine-1-carboxylate (0.322 g, 38.0 %) as a yellow oil which crystallised on standing. This was then combined with EN06111-39-01.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-c9d3e32c4ae3434fab0938e5982b9ebd
出典メモ750 AstraZeneca ELN dataset